Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus

Sera from patients with systemic lupus erythematosus contain specific autoantibodies directed against different polypeptide components of the multicatalytic proteinase (also known as proteasome or prosome). These human autoantibodies, in contrast to polyclonal antibodies obtained in rabbits against...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1991
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118784/
https://www.ncbi.nlm.nih.gov/pubmed/1703207
_version_ 1782141106840928256
collection PubMed
description Sera from patients with systemic lupus erythematosus contain specific autoantibodies directed against different polypeptide components of the multicatalytic proteinase (also known as proteasome or prosome). These human autoantibodies, in contrast to polyclonal antibodies obtained in rabbits against the purified enzyme, recognize highly conserved epitopes of the multicatalytic proteinase polypeptides from yeast to human.
format Text
id pubmed-2118784
institution National Center for Biotechnology Information
language English
publishDate 1991
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21187842008-04-17 Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus J Exp Med Articles Sera from patients with systemic lupus erythematosus contain specific autoantibodies directed against different polypeptide components of the multicatalytic proteinase (also known as proteasome or prosome). These human autoantibodies, in contrast to polyclonal antibodies obtained in rabbits against the purified enzyme, recognize highly conserved epitopes of the multicatalytic proteinase polypeptides from yeast to human. The Rockefeller University Press 1991-02-01 /pmc/articles/PMC2118784/ /pubmed/1703207 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
title Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
title_full Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
title_fullStr Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
title_full_unstemmed Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
title_short Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
title_sort autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118784/
https://www.ncbi.nlm.nih.gov/pubmed/1703207

Ejemplares similares